During the past decade, Wits Clinical Research conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 9 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 7 clinical trials were completed. i.e. 140% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wits Clinical Research" #1 sponsor was "Allergan" with 4 trials, followed by "Pfizer" with 4 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "Clover Biopharmaceuticals AUS Pty Ltd" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wits Clinical Research" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 3 trials as a collaborator, "Astellas Pharma Inc" with 2 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "Coalition for Epidemic Preparedness Innovations" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Wits Clinical Research" are "Gastroparesis" (4 trials), "Diabetes Mellitus" (3 trials), "Systemic Lupus Erythematosus" (2 trials), "COVID-19" (1 trials) and "Cervical Cancer" (1 trials). Many other conditions were trialed in "Wits Clinical Research" in a lesser frequency.

Most popular intervention types in "Wits Clinical Research" are "Drug" (16 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Relamorelin" (3 trials), "Bevacizumab" (2 trials), "Paclitaxel" (2 trials) and "5-FU" (1 trials). Other intervention names were less common.

The vast majority of trials in "Wits Clinical Research" are 14 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Wits Clinical Research". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Wits Clinical Research, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Wits Clinical Research, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".